Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects

被引:43
作者
Altinova, Alev E. [1 ]
Toruner, Fusun [1 ]
Bukan, Neslihan [2 ]
Yasar, Demet Gokalp [3 ]
Akturk, Mujde [1 ]
Cakir, Nuri [1 ]
Arslan, Metin [1 ]
机构
[1] Gazi Univ, Dept Endocrinol & Metab, TR-06550 Ankara, Turkey
[2] Gazi Univ, Dept Biochem, TR-06550 Ankara, Turkey
[3] Gazi Univ, Dept Internal Med, TR-06550 Ankara, Turkey
关键词
adiponectin; overweight; insulin resistance; HDL cholesterol;
D O I
10.1507/endocrj.K06-021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to investigate plasma adiponectin concentration and its relation with metabolic parameters in overweight and normal weight subjects. The study was carried out in 46 overweight subjects (20 male, 26 female; mean age 39.4 +/- 10.2 years) and 48 (19 male, 29 female; mean age 36.1 +/- 10.6 years) sex- and age-matched normal weight subjects. Anthropometric measurements were recorded and adiponectin, glucose, insulin, lipid profile, total homocysteine (tHcy) and fibrinogen levels were measured. The insulin resistance index was assessed by homeostasis model assessment for insulin resistance (HOMA-IR). Plasma mean adiponectin concentrations of the overweight subjects were significantly lower than those of normal weight subjects (15.0 +/- 4.2 vs 17.3 +/- 5.6 ng/ml) (P < 0.05). In overweight subjects, adiponectin levels negatively correlated with body weight (r = -0.35, P < 0.001), body mass index (BMI) (r = -0.28, P < 0.006), systolic blood pressure (r = -0.21, P < 0.04), fasting insulin (r=-0.19, P < 0.01) and HOMA-IR (r=-0.20, P < 0.01) and positively with high-density lipoprotein cholesterol (HDL-C) (r = 0.27, P < 0.009). Overweight subjects with low HDL-C levels had significantly decreased plasma adiponectin levels compared to those with high HDL-C levels (P < 0.05). Multiple regression analysis revealed that BMI, HOMA-IR and HDL-C explained 12%, 20% and 15% variance of the adiponectin concentrations. These findings may suggest that circulating adiponectin is associated with insulin resistance and HDL-C levels independent from BMI in overweight subjects.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 31 条
[1]   Discrimination between obesity and insulin resistance in the relationship with adiponectin [J].
Abbasi, F ;
Chu, JW ;
Lamendola, C ;
McLaughlin, T ;
Hayden, J ;
Reaven, GM ;
Reaven, PD .
DIABETES, 2004, 53 (03) :585-590
[2]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[3]   Risks of obesity [J].
Bray, GA .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2003, 32 (04) :787-+
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   Adiponectinemia in visceral obesity:: Impact on glucose tolerance and plasma lipoprotein and lipid levels in men [J].
Côté, M ;
Mauriège, P ;
Bergeron, J ;
Alméras, N ;
Tremblay, A ;
Lemieux, I ;
Després, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1434-1439
[6]   Hyperadiponectinaemia in anorexia nervosa [J].
Delporte, ML ;
Brichard, SM ;
Hermans, MP ;
Beguin, C ;
Lambert, M .
CLINICAL ENDOCRINOLOGY, 2003, 58 (01) :22-29
[7]   The role of the novel adipocyte-derived hormone adiponectin in human disease [J].
Díez, JJ ;
Iglesias, P .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (03) :293-300
[8]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[9]   Emerging risk factors for atherosclerotic vascular disease - A critical review of the evidence [J].
Hackam, DG ;
Anand, SS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :932-940
[10]   Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin [J].
Havel, PJ .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (01) :51-59